论文部分内容阅读
目的观察黄芪注射液并曲美他嗪片在治疗窦性心动过缓的临床疗效。方法对已确诊的窦性心动过缓患者150例应用黄芪注射液联合曲美他嗪片治疗,6个月后进行疗效观察。根据治疗前后临床症状、动态心电图24 h平均心率、心电图R-R间期等作为评价标准。结果临床症状明显改善,动态心电图24 h平均心率显著提高、心电图R-R间期缩短,无不良反应发生。结论黄芪注射液并曲美他嗪片治疗窦性心动过缓,疗效确切。
Objective To observe the clinical efficacy of astragalus injection and trimetazidine tablets in the treatment of sinus bradycardia. Methods A total of 150 patients with confirmed sinus bradycardia were treated with astragalus injection combined with trimetazidine. The therapeutic effect was observed after 6 months. According to the clinical symptoms before and after treatment, 24 h ECG Holter, R-R interval of electrocardiogram as the evaluation criteria. Results The clinical symptoms were significantly improved. The mean heart rate at 24 h was significantly increased, and the R-R interval of ECG was shortened without any adverse reaction. Conclusion Astragalus injection and trimetazidine tablets treatment of sinus bradycardia, the exact effect.